Amplifon SpA (AMFPF)
12.01
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Amplifon Enterprise Value : 4.354B for June 9, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| June 09, 2026 | 4.354B |
| June 08, 2026 | 4.354B |
| June 05, 2026 | 4.354B |
| June 04, 2026 | 4.354B |
| June 03, 2026 | 4.354B |
| June 02, 2026 | 4.354B |
| June 01, 2026 | 4.354B |
| May 29, 2026 | 4.354B |
| May 28, 2026 | 4.354B |
| May 27, 2026 | 4.898B |
| May 26, 2026 | 4.898B |
| May 22, 2026 | 4.898B |
| May 21, 2026 | 4.242B |
| May 20, 2026 | 4.486B |
| May 19, 2026 | 4.486B |
| May 18, 2026 | 4.486B |
| May 15, 2026 | 4.486B |
| May 14, 2026 | 4.486B |
| May 13, 2026 | 4.486B |
| May 12, 2026 | 4.486B |
| May 11, 2026 | 4.334B |
| May 08, 2026 | 4.334B |
| May 07, 2026 | 4.334B |
| May 06, 2026 | 4.334B |
| May 05, 2026 | 4.334B |
| Date | Value |
|---|---|
| May 04, 2026 | 4.020B |
| May 01, 2026 | 4.020B |
| April 30, 2026 | 4.020B |
| April 29, 2026 | 4.020B |
| April 28, 2026 | 3.931B |
| April 27, 2026 | 3.931B |
| April 24, 2026 | 3.931B |
| April 23, 2026 | 3.931B |
| April 22, 2026 | 3.931B |
| April 21, 2026 | 3.931B |
| April 20, 2026 | 3.931B |
| April 17, 2026 | 3.931B |
| April 16, 2026 | 3.931B |
| April 15, 2026 | 3.931B |
| April 14, 2026 | 3.931B |
| April 13, 2026 | 3.931B |
| April 10, 2026 | 3.931B |
| April 09, 2026 | 3.931B |
| April 08, 2026 | 3.931B |
| April 07, 2026 | 3.931B |
| April 06, 2026 | 3.931B |
| April 02, 2026 | 3.931B |
| April 01, 2026 | 3.931B |
| March 31, 2026 | 3.931B |
| March 30, 2026 | 3.996B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Interpace Biosciences, Inc. | 46.63M |
| Medical Marijuana, Inc. | 2.962M |
| DiaSorin SpA | 4.496B |
| Akso Health Group | 31.28M |
| Acro Biomedical Co. Ltd. | 1.932M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 12.37M |
| Revenue (Quarterly) | 678.28M |
| Total Expenses (Quarterly) | 665.97M |
| EPS Diluted (Quarterly) | 0.0544 |
| Gross Profit Margin (Quarterly) | 11.02% |
| Profit Margin (Quarterly) | 1.82% |
| Earnings Yield | 2.92% |
| Operating Earnings Yield | 8.93% |
| Normalized Earnings Yield | 3.388 |